EB Clinical Management
29 March 2023

Mapping the burden of severe forms of epidermolysis bullosa – Implications for patient management

JAAD Int. 2023 Mar 29;11:224-232. doi: 10.1016/j.jdin.2023.02.016. PMID: 37179539; PMCID: PMC10173168. Mapping the burden of severe forms of epidermolysis bullosa – Implications for patient management Authors: […]
25 April 2023

Trametinib-Induced Epidermal Thinning Accelerates a Mouse Model of Junctional Epidermolysis Bullosa

Biomolecules. 2023 Apr 25;13(5):740. doi: 10.3390/biom13050740. PMID: 37238610; PMCID: PMC10216840. Trametinib-Induced Epidermal Thinning Accelerates a Mouse Model of Junctional Epidermolysis Bullosa Authors: Grace Tartaglia 1, Pyung Hun Park 1, Michael […]
26 April 2023

A Case of Recessive Dystrophic Epidermolysis Bullosa Associated Colitis

JPGN Rep. 2023 Apr 26;4(2):e313. doi: 10.1097/PG9.0000000000000313. PMID: 37200727; PMCID: PMC10187860. A Case of Recessive Dystrophic Epidermolysis Bullosa Associated Colitis Authors: Katelyn McCann 1, Karen Wiss 1 2, Jeffrey Covington 3, Vanessa Laffert 1, Kerri B Gosselin 1 Affiliation: […]
18 May 2023

Measuring the impact of pruritus in patients with epidermolysis bullosa: evaluation with an itch-specific instrument

Dermatology Reports 2023; 15:9700 Measuring the impact of pruritus in patients with epidermolysis bullosa: evaluation with an itch-specific instrument Authors: Ashjan Alheggi,1 Raneem Alnutaifi,2 Manal Alkhonezan,2 […]
24 May 2023

Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5+ Mesenchymal Stromal Cell Treatment in Recessive Dystrophic Epidermolysis Bullosa

Cells. 2023 May 24;12(11):1468. doi: 10.3390/cells12111468. PMID: 37296590; PMCID: PMC10252830. Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5+ Mesenchymal Stromal Cell Treatment […]
1 June 2023

Success of dupilumab in itchy recessive dystrophic epidermolysis bullosa of non-pruriginosa subtype

J Dermatol. 2023 Jun;50(6):837-842. doi: 10.1111/1346-8138.16729. Epub 2023 Jan 24. PMID: 36694424. Success of dupilumab in itchy recessive dystrophic epidermolysis bullosa of non-pruriginosa subtype Authors: Xue-Ge […]
26 June 2023

Characterization of wound microbes in epidermolysis bullosa: A focus on Pseudomonas aeruginosa.

Keywords: epidermolysis bullosa; infection-bacterial; therapy-topical.
4 July 2023

ABSTRACT: Compassionate use of topical beremagene geperpavec (B-VEC) for the treatment of recurrent cicatrizing conjunctivitis in a patient with dystrophic epidermolysis bullosa

Keywords: B-VEC, Krystal, Opthalmology, Gene therapy
4 July 2023

BG04 Oleogel-S10 (birch triterpenes) in the treatment of epidermolysis bullosa wounds: 24-month efficacy and safety data from the EASE study

Keywords: Oleogel-S10, Amryt, Abstract